BGI Works with Multiple Organizations to Launch “Medicinal Plants 4.0”
华大联合多家单位发布“药用植物4.0计划”,并与广西药用植物园签订战略合作协议

Gut microbiome and serum metabolome alterations in obesity and after weight-lossintervention

On June 19, 2017, researchers from the Ruijin Hospital of Shanghai Jiaotong University School of Medicine and BGI Group Co. Ltd completed a study on the correlation between the gut microbiota, circulating amino acids and the clinical indices of lean and obesity in Chinese young adults, and established a classification and prediction model for metagenome and clinical indicators via correlation analysis of metagenomic data in combination with serum metabonomic and proteomic means. This study clarifies the molecular mechanism underlying the onset and development of obesity, providing theoretical basis for the establishment of molecular subtypes and the prediction of clinical outcomes of obesity. The results are published in Nature Medicine, one of the world-famous Nature journals.


Further Reading
Gut microbiome and serum metabolome alterations in obesity and after weight-lossintervention